EP Patent

EP4135640B1 — Adjustable glaucoma treatment devices and associated systems

Assigned to Shifamed Holdings LLC · Expires 2025-12-24 · 0y expired

What this patent protects

Patent listed against Travatan.

Drugs covered by this patent

Travatan (TRAVOPROST)

Patent Metadata

Patent number: EP4135640B1
Jurisdiction: EP
Classification: —
Expires: 2025-12-24
Drug substance claim: No
Drug product claim: No
Assignee: Shifamed Holdings LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.